Since 2002, Dana-Farber has sent its Mammography Van around Boston to provide breast cancer screenings to women who otherwise wouldn’t get checked. Dana-Farber uses data from patient surveys to determine exactly where the mobile unit’s services are needed.
Rosenberg, ScD, led a survey that found women who have double mastectomies
generally overestimate their likelihood of getting cancer in the healthy
E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine
significantly prolonged progression-free survival in patients with progressive
HER2-positive advanced breast cancer.
Tags: BasicResearch, BreastCancer
Dr. Harold Burstein commented on new breast cancer screening guidelines from the American Cancer Society.
Dr. Ann Partridge helped launch a new app, called ResearchKit, part of Apple's mobile health program. The app will allow researchers to access data from breast cancer survivors to provide improved post-treatment quality of life.
Eric P. Winer co-chaired an expert panel that developed a clinical practice
guideline on disease management for patients with advanced HER2-positive breast
cancer and brain metastases.
Tags: BreastCancer, CervicalCancer, OvarianCancer, GynecologicCancers
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: